• About WordPress
    • WordPress.org
    • Documentation
    • Learn WordPress
    • Support
    • Feedback
  • Log In
  • Register
  • Notifications
    Notifications
  • News Feed
  • My Courses
  • Log In
  • Courses
    • Courses
    • Friday 483s Live
  • Blog
    • Blog
    • Podcast
  • Organizations
    • How we can help
    • Schedule a Demo
    • Group Pricing
    • Group Registration
  • About
    • About Us
    • Contact Us
    • Privacy Policy, Terms of Service & EULA
  • My account
  • News Feed
    Sign in Sign up
    • Courses
      • Courses
      • Friday 483s Live
    • Blog
      • Blog
      • Podcast
    • Organizations
      • How we can help
      • Schedule a Demo
      • Group Pricing
      • Group Registration
    • About
      • About Us
      • Contact Us
      • Privacy Policy, Terms of Service & EULA
    • My account
    • News Feed

    Tag: 483

    FDA 483 #9 – Bacterial Endotoxin Testing

    Learning Objectives Discuss the importance of low levels of endotoxins in parenteral preparations Discuss the limits for endotoxins for various routes of administration Discuss ways…

    Seth DePasquale, R.Ph., BCSCP October 16, 2020
    0 Comments

    483 #4 – Investigations & CAPAs

    Learning Objectives Explain how action levels are used to maintain a controlled environment Define the 5 steps to DMAIC Explain the 5 why’s technique for…

    Seth DePasquale, R.Ph., BCSCP September 8, 2020
    0 Comments

    483 #3 – Smoke Studies and Media Fills

    Learning Objectives Explain the purpose of smoke studies Define the two types of smoke studies that need to be performed Explain the two conditions under…

    Seth DePasquale, R.Ph., BCSCP September 3, 2020
    2 Comments

    Getting an FDA “Close Out Letter”

    An FDA Inspection So you’ve been visited by the FDA and whether you’re a seasoned QA manager at a major pharmaceutical manufacturer or the pharmacist…

    Seth DePasquale, R.Ph., BCSCP August 27, 2020
    0 Comments

    You received a 483? Don’t Panic…

    An FDA Inspection So you’ve been visited by the FDA and whether you’re a seasoned QA manager at a major pharmaceutical manufacturer or the pharmacist…

    Seth DePasquale, R.Ph., BCSCP August 24, 2020
    1 Comment

    483 #2 – Facilities & Equipment

    Learning Objectives Explain the conditions USP Chapter <797> states for surfaces in classified areas Discuss what USP Chapter <797> says about gaps in ceiling tiles…

    Seth DePasquale, R.Ph., BCSCP August 21, 2020
    0 Comments

    Recent Posts

    • FDA 483 #10 – Non-Viable Particle Counting
    • FDA 483 #9 – Bacterial Endotoxin Testing
    • Pharmacy Inspection Podcast – Episode 48 – Can we share stability studies?
    • Can we share Stability Studies?
    • FDA 483 #8 – Using ungraded ingredients

    Recent Comments

    • Bret Snow on You received a 483? Don’t Panic…
    • Rick Meyer on Pharmacy Inspection Podcast – Episode 44 – Is my building right for my compounding pharmacy?
    • Seth DePasquale, R.Ph., BCSCP on Cleaning up Confusion; correctly cleaning your room
    • Rick Meyer on Pharmacy Inspection Podcast – Episode 46 – HEPA Filtered Exhaust
    • Seth on 483 #3 – Smoke Studies and Media Fills
    © 2025 - Sterile.AF
    483 #2 - Facilities & Equipment

    Report

    There was a problem reporting this post.

    Block Member?

    Please confirm you want to block this member.

    You will no longer be able to:

    • See blocked member's posts
    • Mention this member in posts
    • Invite this member to groups
    • Message this member
    • Add this member as a connection

    Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

    Report

    You have already reported this .